Hyperhomocysteinemia and Low Pyridoxal Phosphate
- 15 November 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 92 (10), 2825-2830
- https://doi.org/10.1161/01.cir.92.10.2825
Abstract
Background High plasma homocysteine is associated with premature coronary artery disease in men, but the threshold concentration defining this risk and its importance in women and the elderly are unknown. Furthermore, although low B vitamin status increases homocysteine, the link between these vitamins and coronary disease is unclear. Methods and Results We compared 304 patients with coronary disease with 231 control subjects. Risk factors and concentrations of plasma homocysteine, folate, vitamin B12, and pyridoxal 5′-phosphate were documented. A homocysteine concentration of 14 μmol/L conferred an odds ratio of coronary disease of 4.8 (P<.001), and 5-μmol/L increments across the range of homocysteine conferred an odds ratio of 2.4 (P<.001). Odds ratios of 3.5 in women and of 2.9 in those 65 years or older were seen (P<.05). Homocysteine correlated negatively with all vitamins. Low pyridoxal 5′-phosphate (<20 nmol/L) was seen in 10% of patients but in only 2% of control subjects (P<.01), yielding an odds...Keywords
This publication has 29 references indexed in Scilit:
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994
- Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular diseaseAtherosclerosis, 1992
- Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factorsEuropean Journal of Clinical Investigation, 1992
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease Effects of pyridoxine and folic acid treatmentAtherosclerosis, 1990
- Pyridoxine reduces cholesterol and low-density lipoprotein and increases antithrombin III activity in 80-year-old men with low plasma pyridoxal 5-phosphateScandinavian Journal of Clinical and Laboratory Investigation, 1990
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- The pathogenesis of coronary artery disease. A possible role for methionine metabolism.Journal of Clinical Investigation, 1976
- Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern IrelandArchives of Disease in Childhood, 1962